SCHEMBL16513550

SCHEMBL16513550

CN1CCN(c2ccc(Nc3ncc4cccc(-c5cc(C=CC(N)=O)ccc5Cl)c4n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.53
JAK2 O60674 2/20 0.53
SLC2A1 P11166 1/20 0.50
FGFR4 P22455 3/20 0.49
FGFR1 P11362 3/20 0.49
FGFR2 P21802 2/20 0.49
SRC P12931 2/20 0.49
FGFR3 P22607 1/20 0.49
EGFR P00533 3/20 0.49
BTK Q06187 1/20 0.48
LCK P06239 1/20 0.48
MAPK14 Q16539 1/20 0.48
ALK Q9UM73 1/20 0.47
WEE1 P30291 2/20 0.47
MAP3K7 O43318 1/20 0.47
MAPK1 P28482 1/20 0.47
MAP2K1 Q02750 1/20 0.47
JAK3 P52333 2/20 0.47
BLK P51451 1/20 0.47
BMX P51813 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16514634 0.91 BRD4 (0.53) BRD4JAK2SLC2A1FGFR4FGFR1
SCHEMBL16513654 0.83 BTK (0.68) JAK2FGFR1FGFR2SRCEGFR
SCHEMBL29847942 0.83 BTK (0.68) JAK2FGFR1FGFR2SRCEGFR
SCHEMBL16513811 0.83 BRD4 (0.60) BRD4JAK2SLC2A1FGFR4FGFR1
SCHEMBL16513994 0.82 EGFR (0.63) BRD4JAK2FGFR1FGFR2EGFR
SCHEMBL16514597 0.80 TTK (0.56) BRD4JAK2FGFR1FGFR2SRC
SCHEMBL19096959 0.79 MAPK10 (0.55) BRD4JAK2FGFR2EGFRBTK
SCHEMBL93524 0.79 MAP3K7 (0.57) BRD4JAK2SLC2A1FGFR1SRC
SCHEMBL93511 0.79 EGFR (0.69) BRD4JAK2SLC2A1EGFRBTK
SCHEMBL16514973 0.79 EGFR (0.52) BRD4JAK2FGFR1FGFR2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed